10-Apr-2026
Lifeward Successfully Closes on Strategic Partnership with Oramed
Globe Newswire (Wed, 25-Mar 4:10 PM ET)
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
Globe Newswire (Wed, 18-Mar 8:00 AM ET)
Globe Newswire (Fri, 13-Mar 8:00 AM ET)
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
Globe Newswire (Wed, 11-Mar 8:00 AM ET)
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
Globe Newswire (Tue, 10-Mar 4:15 PM ET)
Globe Newswire (Mon, 2-Mar 8:00 AM ET)
Globe Newswire (Wed, 25-Feb 8:00 AM ET)
Lifeward Announces Reverse Share Split
Globe Newswire (Fri, 20-Feb 8:00 AM ET)
Globe Newswire (Tue, 17-Feb 8:00 AM ET)
Lifeward Secures $47 Million Strategic Investment with Oramed to Expand into Biotech and MedTech
Market Chameleon (Tue, 13-Jan 5:33 AM ET)
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.
Lifeward Ltd. - trades on the NASDAQ stock market under the symbol LFWD.
As of April 10, 2026, LFWD stock price declined to $6.57 with 3,756 million shares trading.
LFWD has a beta of 0.50, meaning it tends to be less sensitive to market movements. LFWD has a correlation of 0.01 to the broad based SPY ETF.
LFWD has a market cap of $24.87 million. This is considered a Sub-Micro Cap stock.
Last quarter Lifeward Ltd. - reported $5 million in Revenue and -$2.85 earnings per share. This fell short of revenue expectation by $-3 million and missed earnings estimates by -$1.87.
LFWD has underperformed the market in the last year with a price return of -60.6% while the SPY ETF gained +30.9%. LFWD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.0% and +2.2%, respectively, while the SPY returned -1.8% and +7.2%, respectively.
LFWD support price is $6.17 and resistance is $7.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFWD shares will trade within this expected range on the day.